Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Navigational Bronchoscopy PDT with Photofrin and Lipiodol for Lung Tumors
NCT04753918Phase 1Unknown
- Sponsor
- Taoyuan General Hospital
- Start
- Mar 2021
- Primary completion
- Sep 2021
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of porfimer sodium and ethiodized oil in non-small cell lung cancer (NSCLC) and cancer, sponsored by Taoyuan General Hospital. Primary endpoints: Feasibility to Perform Novel Photodynamic Therapy Into Tumor at 3 days and Adverse Events Incidence Indicating Safety of Novel Photodynamic Therapy at 6 months. Status: unknown.
02
Drugs
porfimer sodiumethiodized oil
03
Conditions
non-small cell lung cancer (NSCLC)cancer
Beyond the preview
Go deeper on NCT04753918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04753918.